Preclinical Imaging Market Size to Grow US$ 8.35 Billion By 2030

The global preclinical imaging market size was valued at US$ 4.92 billion in 2022 and is anticipated to grow US$ 8.35 billion by 2030, registering a compound annual growth rate of 6.82% from 2022 to 2030.

The preclinical imaging market report covering various industry elements and growth trends helpful for predicting the market’s future.

The study provides a strong base for the preclinical imaging market to be segmented into different segments. In fact, the study also covers the maximum market share during the assessment period by 2030.

This study is based on the partners that are highly competitive, key players as well as their market revenue in the forecast years of 2022 to 2030. There is also a strong focus on product revenues, sales, product categories and even the products that are experiencing the most traction. In this manner, the preclinical imaging report also speaks about the effectiveness of this market along with its growth during the forecast period of 2030. Other major attributes of the preclinical imaging market have been studied and analysed across many developments.

Preclinical Imaging Market Report Scope 

Also read: Molten Salt Thermal Energy Storage Market Size to Grow US$ 22.43 Billion By 2030

Research Approach

The comprehensive report on the global preclinical imaging market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. Following this, the report provides detailed explanation of objectives of this study and laid down by accredited agencies in the purview of research in the global preclinical imaging market.

It is followed by market introduction, market dynamics, and an overview of the global market, which includes analysis of market drivers, restraints, and trends pertaining to the global market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Key Players 

• Bruker Corporation (US)
• MR Solutions (UK)
• PerkinElmer (US)
• Fujifilm Holdings Corporation (Japan)
• Milabs B.V. (The Netherlands)
• Mediso Ltd. (Hungary)
• Miltenyi Biotec GmbH (Germany)
• LI-COR
• Inc. (US)
• Aspect Imaging (Israel)
• Trifoil Imaging (US)

Preclinical Imaging Market Segmentations

By Product

• CT Imaging
• MRI Imaging
• PET/SPECT Imaging
• Multi-modal Imaging
• Optical Imaging
• Ultrasound Imaging
• Photoacoustic Imaging
• Reagents
• Services

By End-User

• Biotech Companies
• Pharmaceutical Companies
• Research Institutes

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Preclinical Imaging Market 

5.1. COVID-19 Landscape: Preclinical Imaging Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Preclinical Imaging Market, By Product

8.1. Preclinical Imaging Market, by Product, 2022-2030

8.1.1. CT Imaging

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. MRI Imaging

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. PET/SPECT Imaging

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. PET/SPECT Imaging

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Optical Imaging

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Ultrasound Imaging

8.1.6.1. Market Revenue and Forecast (2017-2030)

8.1.7. Photoacoustic Imaging

8.1.7.1. Market Revenue and Forecast (2017-2030)

8.1.8. Reagents

8.1.8.1. Market Revenue and Forecast (2017-2030)

8.1.9. Services

8.1.9.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Preclinical Imaging Market, By End-User

9.1. Preclinical Imaging Market, by End-User, 2022-2030

9.1.1. Biotech Companies

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Pharmaceutical Companies

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Research Institutes

9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Preclinical Imaging Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Product (2017-2030)

10.1.2. Market Revenue and Forecast, by End-User (2017-2030)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.1.3.2. Market Revenue and Forecast, by End-User (2017-2030)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.1.4.2. Market Revenue and Forecast, by End-User (2017-2030)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Product (2017-2030)

10.2.2. Market Revenue and Forecast, by End-User (2017-2030)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.2.3.2. Market Revenue and Forecast, by End-User (2017-2030)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.2.4.2. Market Revenue and Forecast, by End-User (2017-2030)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

10.2.5.2. Market Revenue and Forecast, by End-User (2017-2030)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

10.2.6.2. Market Revenue and Forecast, by End-User (2017-2030)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.3.2. Market Revenue and Forecast, by End-User (2017-2030)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.3.3.2. Market Revenue and Forecast, by End-User (2017-2030)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.3.4.2. Market Revenue and Forecast, by End-User (2017-2030)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

10.3.5.2. Market Revenue and Forecast, by End-User (2017-2030)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

10.3.6.2. Market Revenue and Forecast, by End-User (2017-2030)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.4.2. Market Revenue and Forecast, by End-User (2017-2030)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.4.3.2. Market Revenue and Forecast, by End-User (2017-2030)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.4.4.2. Market Revenue and Forecast, by End-User (2017-2030)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

10.4.5.2. Market Revenue and Forecast, by End-User (2017-2030)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

10.4.6.2. Market Revenue and Forecast, by End-User (2017-2030)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Product (2017-2030)

10.5.2. Market Revenue and Forecast, by End-User (2017-2030)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.5.3.2. Market Revenue and Forecast, by End-User (2017-2030)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.5.4.2. Market Revenue and Forecast, by End-User (2017-2030)

Chapter 11. Company Profiles

11.1. Bruker Corporation (US)

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. MR Solutions (UK)

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. PerkinElmer (US)

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Fujifilm Holdings Corporation (Japan)

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Milabs B.V. (The Netherlands)

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Mediso Ltd. (Hungary)

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Mediso Ltd. (Hungary)

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. LI-COR

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Inc. (US)

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Aspect Imaging (Israel)

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Why should you invest in this report?

If you are aiming to enter the global preclinical imaging market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for preclinical imaging are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Request a Sample Copy of This Report @ https://www.precedenceresearch.com/sample/2345

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com